Cybin to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit

BusinesswireSep 24 07:30 ET

Strong Buy Rating for Cybin Inc. on Promising Clinical Advances and Strategic Management Positioning

TipRanksSep 24 04:15 ET · Ratings

Cybin Inc To Carry Out 1-for-38 Reverse Stock Split On September 19th, 2024

Moomoo NewsAug 28 06:35 ET

Cybin Inc. Shareholders Approve Key Decisions

TipRanksAug 27 19:37 ET

Express News | Cybin Inc: Pivotal Trial Designs Incorporate Elements to Address Functional Unblinding

ReutersAug 13 07:30 ET

Express News | Cybin Inc: Expects to Initiate Phase 3 Pivotal Trial in Late Summer 2024

ReutersAug 13 07:30 ET